Commerzbank Aktiengesellschaft FI Lowers Stock Holdings in CVS Health Corporation (NYSE:CVS)

Commerzbank Aktiengesellschaft FI reduced its stake in CVS Health Corporation (NYSE:CVS - Free Report) by 47.4% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 54,176 shares of the pharmacy operator's stock after selling 48,815 shares during the period. Commerzbank Aktiengesellschaft FI's holdings in CVS Health were worth $3,670,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of CVS. Madison Investment Advisors LLC acquired a new stake in shares of CVS Health in the fourth quarter valued at $6,233,000. Cibc World Markets Corp increased its holdings in CVS Health by 16.4% in the fourth quarter. Cibc World Markets Corp now owns 198,542 shares of the pharmacy operator's stock valued at $8,913,000 after buying an additional 27,985 shares during the last quarter. Cozad Asset Management Inc. increased its holdings in CVS Health by 3.7% in the fourth quarter. Cozad Asset Management Inc. now owns 6,532 shares of the pharmacy operator's stock valued at $293,000 after buying an additional 233 shares during the last quarter. Thrivent Financial for Lutherans increased its holdings in CVS Health by 4.9% in the fourth quarter. Thrivent Financial for Lutherans now owns 95,518 shares of the pharmacy operator's stock valued at $4,380,000 after buying an additional 4,463 shares during the last quarter. Finally, Advisors Asset Management Inc. increased its holdings in CVS Health by 41.6% in the fourth quarter. Advisors Asset Management Inc. now owns 189,208 shares of the pharmacy operator's stock valued at $8,494,000 after buying an additional 55,542 shares during the last quarter. 80.66% of the stock is currently owned by institutional investors and hedge funds.

CVS Health Price Performance

Shares of CVS stock traded down $1.36 during midday trading on Friday, reaching $61.94. 8,610,279 shares of the company traded hands, compared to its average volume of 10,745,486. The firm's 50 day simple moving average is $64.80 and its two-hundred day simple moving average is $62.76. CVS Health Corporation has a 1-year low of $43.56 and a 1-year high of $72.51. The company has a debt-to-equity ratio of 0.77, a current ratio of 0.82 and a quick ratio of 0.63. The firm has a market cap of $78.36 billion, a PE ratio of 14.78, a price-to-earnings-growth ratio of 0.91 and a beta of 0.57.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.62 by $0.63. CVS Health had a net margin of 1.39% and a return on equity of 10.59%. The company had revenue of $94.59 billion during the quarter, compared to the consensus estimate of $93.07 billion. During the same period last year, the firm earned $1.31 EPS. The company's revenue for the quarter was up 7.0% on a year-over-year basis. On average, equities research analysts expect that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 1st. Stockholders of record on Tuesday, July 22nd will be paid a dividend of $0.665 per share. The ex-dividend date of this dividend is Tuesday, July 22nd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.29%. CVS Health's dividend payout ratio (DPR) is 63.48%.

Insider Buying and Selling at CVS Health

In other CVS Health news, Director Guy P. Sansone acquired 1,570 shares of the company's stock in a transaction dated Thursday, June 5th. The stock was acquired at an average cost of $63.70 per share, with a total value of $100,009.00. Following the purchase, the director directly owned 12,007 shares in the company, valued at approximately $764,845.90. This trade represents a 15.04% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this link. 1.22% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several research firms recently commented on CVS. Mizuho increased their target price on CVS Health from $70.00 to $76.00 and gave the company an "outperform" rating in a report on Wednesday, April 9th. Cowen reaffirmed a "buy" rating on shares of CVS Health in a report on Monday, May 5th. UBS Group raised their price objective on CVS Health from $67.00 to $71.00 and gave the stock a "neutral" rating in a report on Friday, May 2nd. Morgan Stanley reaffirmed an "overweight" rating on shares of CVS Health in a report on Tuesday, April 15th. Finally, Wells Fargo & Company reaffirmed an "overweight" rating and set a $84.00 price objective (up previously from $76.00) on shares of CVS Health in a report on Tuesday, May 6th. Two research analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $75.06.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.